NeurogesX Initiate Phase I of NGX-1998 Capsaicin Liquid Formulation « Ion channel News

NeurogesX Initiate Phase I of NGX-1998 Capsaicin Liquid Formulation

Posted on July 14, 2008 by crimsoncanary

NeurogesX has initiated a Phase 1 clinical trial of NGX-1998, a high-concentration, capsaicin-based liquid formulation designed to deliver a localized therapeutic dose directly to the pain site.

Filed under: Ion Channel | Tagged: agonist, Capsaicin, NeurogesX, NGX-1998, NGX1998, TRPV1, Vanilloid

« Ranolazine receives EU marketing authorization for Chronic Angina Phase IIb results show Vernakalant effective in atrial fibrillation »

Leave a Reply